| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.1 | 0.8 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |